Clinical Trial Update: Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT) [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed ceftriaxone to prevent pneumonia and inflammation after out-of-hospital cardiac arrest. The PROTECT study was terminated, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrest
• Pneumonia

Drugs mentioned

• ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: David J. Gagnon | Conditions: Out-Of-Hospital Cardiac Arrest, Pneumonia | Phase 2 | Status: TERMINATED | Results posted: 2025-04-17